New study uses AlphaFold and AI to accelerate design of novel drug for liver cancer
New research uses AlphaFold, an artificial intelligence (AI)-powered protein structure database, to accelerate the design and synthesis of a drug to treat hepatocellular carcinoma (HCC), the most common type of primary liver ...